OBJECTIVES: We examined angiographic and late-term clinical outcomes according to sex in recent percutaneous coronary intervention (PCI) trials involving zotarolimus-eluting stents (ZES). BACKGROUND: Differences in outcome between men and women undergoing PCI have been inconsistently described with bare metal and first-generation drug-eluting stents. METHODS: Clinical and angiographic outcomes among ZES-treated patients were evaluated by sex using propensity score modeling in a patient-level systematic overview of six trials and were also compared to patients receiving bare metal stents (BMS).
Brown, R., Williams, M., Barker, C., Mauri, L., Meredith, I., Fajadet, J., Wijns, W., Leon, M., & Kandzari, D. (2010). Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results. Catheterization and Cardiovascular Interventions, 76(6), 804 - 813. https://doi.org/10.1002/ccd.22624